<?xml version="1.0" encoding="UTF-8"?>
<p>As seen in 
 <xref rid="F0006">Figure 6</xref>, the spectrum of the M2e-specific IgY-ALP bioconjugate observed absorption bands at 3,381 cm
 <sup>−1</sup>, 2,387 cm
 <sup>−1</sup>, 2,308 cm
 <sup>−1</sup>, 1,924 cm
 <sup>−1</sup>, 1,784 cm
 <sup>−1</sup>, 1,647 cm
 <sup>−1</sup>, 1,543 cm
 <sup>−1</sup>, 1,409 cm
 <sup>−1</sup>, 1,315 cm
 <sup>−1</sup>, 997 cm
 <sup>−1</sup>, 773 cm
 <sup>−1</sup>, and 721 cm
 <sup>−1</sup>. The peak found at 1,647 cm
 <sup>−</sup>[
 <xref rid="CIT0001">1</xref>] in the M2e-specific IgY-ALP bioconjugate spectrum indicated the presence of M2e-specific IgY antibody in the conjugate. The peaks seen at 1,639 cm
 <sup>−1</sup> in the spectrum of the M2e-specific IgY antibody (
 <xref rid="F0004">Figure 4</xref>) at 1,641 cm
 <sup>−1</sup> in the spectrum of the ALP enzyme (
 <xref rid="F0005">Figure 5</xref>) were the amid I peak. Due to the bioconjugation reaction between the antibody and enzyme, the amid I band of the M2e-specific IgY antibody shifted to 1,647 cm
 <sup>−1</sup> with a shifting value of 8 cm
 <sup>−1</sup>.
</p>
